Table 1.
Characteristics of included studies.
Studya | Country | Sample size |
Study design | Transplant recipients | Follow-up duration (days) | Definition of severity used | Definition of COVID-19 infection used | Adjusted variables | |
---|---|---|---|---|---|---|---|---|---|
Transplant recipients | Nontransplant controls | ||||||||
Arya [27] | America | 58 | 14,975 | Retrospective | 38 kidney, 8 liver, 5 heart, 3 pancreases, 4 multiorgan transplants | 184 | ICU admission, mechanical ventilation | SARS-CoV-2 RT-PCR (+) | NR |
Avery [19] | America | 45 | 2427 | Retrospective | NR | 173 | Invasive mechanical ventilation | SARS-CoV-2 RT-PCR (+) | NR |
Caillard [8] | France | 273 | 273 | Retrospective | Kidney | 64 (55–71) | Mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Age, BMI, cardiovascular and respiratory diseases, cancer, and diabetes |
Chaudhry [10] | America | 35 | 100 | Retrospective | 38 kidneys and 9 non-kidney organs | 35 (20–36) | ICU admission, mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Age, coexisting conditions, transplant status, and Henry Ford Hospital COVID-19 severity score |
Chavarot [17] | France | 83 | 83 | Retrospective | Kidney | 13 (7–30) | defined as death and/or need for ICU | SARS-CoV-2 RT-PCR (+) | Age, sex, body mass index, diabetes mellitus, preexisting cardiopathy, chronic lung disease and basal renal function. |
Fisher [23] | America | 128 | 3907 | Retrospective | 106 kidneys, 9 livers, 6 hearts, 4 combined kidneys/pancreas, 3 combined kidney/livers | Patients were followed until the first of hospital discharge, death or September 1, 2020 | ICU admission, mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Age, sex, race, ethnicity, BMI, hypertension, diabetes mellitus, congestive heart failure, and obesity (defined as BMI ≥ 30 kg/m2). |
Hardesty [25] | America | 11 | 44 | Retrospective | Kidney | 80 | NR | SARS-CoV-2 RT-PCR (+) | Age and sex |
Linares [26] | Spain | 41 | 220 | Retrospective | 32 kidney, 4 liver, 3 heart, 2 combined kidney/liver | 80 | ICU admission, mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Age, sex, hypertension, lung disease, use of anti-cytokine therapies, baseline clinical status and clinical status during hospitalization |
Miarons [9] | Spain | 46 | 166 | Retrospective | 30 kidneys, 3 livers, 13 lungs | 28 | ICU admission | SARS-CoV-2 RT-PCR (+) | Sex, age and age-adjusted Charlson's Index |
Molnar [11] | America | 98 | 288 | Retrospective | 67 kidneys, 13 livers, 13 hearts, 4 lungs, and 1 pancreas | 28 | Invasive mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Age, gender, race, ethnicity, BMI, comorbidities and medication use prior to hospital admission |
Nair [24] | America | 82 | 1625 | Retrospective | 69 kidneys, 3 livers, 6 hearts, 1 lung, 2 combined kidneys/pancreas, 1 combined kidney/liver | Patients were followed from the date of initial hospitalization until the first outcome of either death, discharge from the hospital, transfer to another center, or end of the study | Invasive mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Age, gender, diabetes, hypertension, and cardiovascular disease (defined as any of coronary artery disease, peripheral arterial disease, or heart failure) |
Ozturk [20] | Turkey | 81 | 450 | Retrospective | Kidney | 28 | ICU admission, mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Age, gender, presence of diabetes, hypertension, cardiovascular disease, COPD and eGFR |
Rinaldi [18] | Italy | 24 | 861 | Prospective | 22 kidneys, 2 livers | 30 | ICU admission | SARS-CoV-2 RT-PCR (+) | NR |
Ringer [22] | America | 30 | 60 | Retrospective | 26 kidneys, 3 livers, 1 heart | 28 | Invasive mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Age, BMI and comorbidities (hypertension and diabetes mellitus with hemoglobin A1c >8.0%) |
Trapani [21] | Italy | 450 | 238,875 | Retrospective | 285 kidneys, 89 livers, 54 hearts, 15 lungs, 8 pancreases | 365 | ICU admission, mechanical ventilation | SARS-CoV-2 RT-PCR (+) | Gender and age |
Age data presented as median (IQR) or mean (SD); ICU: intensive care units; BMI: body mass index; COPD: chronic obstructive pulmonary disease; eGFR: estimated glomerular filtration rate; SARS-CoV-2: 2019 severe acute respiratory syndrome coronavirus 2; RT-PCR: Real-time reverse transcription polymerase chain reaction; NR, not reported.